Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
crawled date : 2021 - 12 - 06 crawled time : 15:30 save search
12/6/2021 – RespireRx Pharmaceuticals Inc. Announces Publication of Review Article Describing Advances in the Discovery, Development and Commercialization of GABAkines, Including KRM-II-81
Published: 2021-12-06 (Crawled : 15:30) - respirerx.com
RSPI | $0.0009 0.0% 5M
|
Manufacturing
|
| O: -21.57%
H: 32.5%
C: 31.67%
commercialization
RespireRx Pharmaceuticals Inc. Announces Publication of Review Article Describing Advances in the Discovery, Development and Commercialization of GABAkines, Including KRM-II-81
Published: 2021-12-06 (Crawled : 15:30) - biospace.com/
RSPI | $0.0009 0.0% 5M
|
Manufacturing
|
| O: -21.57%
H: 32.5%
C: 31.67%
commercialization
PDS Biotech Provides Recruitment update for National Cancer Institute-Led Phase 2 Clinical Trial of PDS0101-Based CombinationInstitutional Review Board (IRB) approval has been obtained and clinical trial recruitment resumes
Published: 2021-12-06 (Crawled : 15:30) - biospace.com/
PDSB | $2.89 6.25% 5.88% 1.1M
|
Health Technology
|
| O: -2.14%
H: 0.0%
C: 0.0%
phase 2 trial approval cancer biotech iot
Bsense Announces Positive Topline Proof-of-Concept Preclinical Data that Supports the Development in Additional Sensory Hyperexcitability Related Disorders
Published: 2021-12-06 (Crawled : 15:30) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 1.49%
H: 0.0%
C: 0.0%
sensor order preclinical positive topline pre-clinical
Yield10 Bioscience to Participate in the Benzinga Global Small Cap Conference on December 9, 2021
Published: 2021-12-06 (Crawled : 15:30) - biospace.com/
YTEN | $0.2727 -2.08% -1.79% 280K
|
Health Technology
|
| O: 0.25%
H: 0.0%
C: 0.0%
conference bioscience
Applied DNA Advances Cotton Genomics-based Methodology for Determination of Authenticity and Provenance
Published: 2021-12-06 (Crawled : 15:30) - biospace.com/
APDN | $0.3376 1.38% 3.79% 130K
|
Commercial Services
|
| O: -3.25%
H: 0.0%
C: 0.0%
genomics genomic
Upadacitinib (RINVOQ®) Achieved Primary and Key Secondary Endpoints in First Phase 3 Induction Study in Patients with Crohn's Disease
Published: 2021-12-06 (Crawled : 15:30) - biospace.com/
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 1.57%
H: 0.0%
C: 0.0%
disease phase 3
Rhythm Pharmaceuticals and RareStone Ltd. Announce Exclusive Licensing Agreement for the Development and Commercialization of IMCIVREE (setmelanotide) in China
Published: 2021-12-06 (Crawled : 15:30) - biospace.com/
RYTM A | $38.11 -0.88% -0.89% 440K
|
Health Technology
|
| O: 0.96%
H: 0.0%
C: 0.0%
commercialization china setmelanotide imcivree license
New Mesoblast Data Offers Hope for High-Risk Heart Patients
Published: 2021-12-06 (Crawled : 15:30) - biospace.com/
MESO | $5.14 2.6% 2.53% 270K
|
Health Technology
|
| O: 5.25%
H: 0.0%
C: 0.0%
heart risk
BioSig to Participate in the Benzinga All Access Event on December 14, 2021
Published: 2021-12-06 (Crawled : 15:30) - globenewswire.com
BSGM | $1.53 -6.14% -6.54% 420K
|
Health Technology
|
| O: -3.04%
H: 0.0%
C: 0.0%
Hub Group presented U.S. EPA SmartWay Excellence Award for the ninth time
Published: 2021-12-06 (Crawled : 15:30) - globenewswire.com
HUBG | $38.74 -0.79% -0.75% 610K
|
Transportation
|
| O: 0.18%
H: 0.0%
C: 0.0%
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $1.45 5.84% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.421 97.65% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.509 23.81% 45.26% 90K
|
GDHG | $0.263 21.76% 40.66% 3.1M
|
XPON | News | $3.15 63.21% 37.74% 16M
|
TIRX | $0.8 65.02% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.